ICD-10 Specific code F13.7: Residual and late-onset psychotic disorder

Translations

Language	Translation
English	Residual and late-onset psychotic disorder
French	Troubles mentaux et du comportement liés à l'utilisation de sédatifs ou d'hypnotiques : trouble résiduel ou psychotique de survenue tardive

Hierarchical position

Level	Code	Title
1	V	Mental and behavioural disorders
2	F10-F19	Mental and behavioural disorders due to psychoactive substance use
3	F13	Mental and behavioural disorders due to use of sedatives or hypnotics
4	F13.7	Residual and late-onset psychotic disorder

Description

A disorder in which alcohol- or psychoactive substance-induced changes of cognition, affect, personality, or behaviour persist beyond the period during which a direct psychoactive substance-related effect might reasonably be assumed to be operating.

Onset of the disorder should be directly related to the use of the psychoactive substance. Cases in which initial onset of the state occurs later than episode(s) of such substance use should be coded here only where clear and strong evidence is available to attribute the state to the residual effect of the psychoactive substance. Flashbacks may be distinguished from psychotic state partly by their episodic nature, frequently of very short duration, and by their duplication of previous alcohol- or other psychoactive substance-related experiences.

Also includes

Alcoholic dementia NOS
Chronic alcoholic brain syndrome
Dementia and other milder forms of persisting impairment of cognitive functions
Flashbacks
Late-onset psychoactive substance-induced psychotic disorder
Posthallucinogen perception disorder
Residual:

• affective disorder
• disorder of personality and behaviour

Does not include

Alcohol- or psychoactive substance-induced:

• Korsakov syndrome (F10-F19 with common fourth character .6)
• psychotic state (F10-F19 with common fourth character .5)

Indicated medicines

Active Ingredient	Description
Tiapride	Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine).